KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Royalty Pharma (RPRX) over the last 6 years, with Q4 2025 value amounting to 0.12.

  • Royalty Pharma's Asset Utilization Ratio fell 222.44% to 0.12 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12, marking a year-over-year decrease of 222.44%. This contributed to the annual value of 0.13 for FY2025, which is 392.86% down from last year.
  • According to the latest figures from Q4 2025, Royalty Pharma's Asset Utilization Ratio is 0.12, which was down 222.44% from 0.12 recorded in Q3 2025.
  • Royalty Pharma's 5-year Asset Utilization Ratio high stood at 0.15 for Q4 2023, and its period low was 0.12 during Q4 2025.
  • In the last 5 years, Royalty Pharma's Asset Utilization Ratio had a median value of 0.13 in 2021 and averaged 0.13.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 1258.62% in 2023, then plummeted by 1454.08% in 2024.
  • Quarter analysis of 5 years shows Royalty Pharma's Asset Utilization Ratio stood at 0.13 in 2021, then dropped by 0.12% to 0.13 in 2022, then rose by 12.59% to 0.15 in 2023, then fell by 14.54% to 0.12 in 2024, then dropped by 2.22% to 0.12 in 2025.
  • Its last three reported values are 0.12 in Q4 2025, 0.12 for Q3 2025, and 0.13 during Q2 2025.